Chronic disease in the UAE, and why consistency matters
What long-term medicines do for diabetes and heart disease, both common in the UAE, and why taking them consistently makes a difference.

How common chronic disease is in the UAE
20.7% of UAE adults live with diabetes on an age-adjusted basis, among the highest prevalence rates in the world (IDF, 2024). That is about 1.3 million adults aged 20 to 79, and a higher rate than in most countries the International Diabetes Federation tracks1, 2.
Heart and blood vessel disease is the leading cause of death. A 2021 national report found that cardiovascular disease causes 34% of all deaths in the UAE3. It was prepared by the Ministry of Health and Prevention with UNDP and WHO3. The four main non-communicable diseases, which include diabetes, cause 55% of deaths3.
The risk factors are widespread. A national survey in 2017 and 2018 found high blood pressure in 28.8% of adults surveyed3. Most adults in the survey with raised blood pressure were not taking medicine for it3. The same survey found that 43.7% of adults had high cholesterol or were taking medicine for it3.
The economic cost is large. Non-communicable disease cost the UAE an estimated AED 39.9 billion in 2019, of which around AED 26 billion was cardiovascular disease. More than half of the total came from lost productivity rather than healthcare spending3.
What long-term medicines are for
Many long-term medicines work quietly. They lower a risk rather than relieve a symptom you can feel.
- Blood pressure medicines. Most people with high blood pressure do not feel any symptoms4. Left untreated, it can lead to kidney disease, heart disease and stroke4. Common medicines relax blood vessels or remove extra water from the body, which lowers blood pressure4.
- Diabetes medicines. Type 2 diabetes stops the body using insulin properly, which can lead to high blood sugar5. Over time, diabetes can cause blindness, kidney failure, heart attacks, stroke and lower limb amputation5. Some people need medicines such as metformin or insulin to manage blood sugar5. Many also need blood pressure medicines and statins to reduce the risk of complications5.
- Statins. These lower LDL cholesterol, sometimes called "bad" cholesterol, by slowing how much cholesterol the liver makes6. Studies have shown that statins lower the risk of heart attack and stroke in people with high LDL cholesterol6.
In each case, the aim is to lower the chance of a serious problem later. It is easy to forget a medicine that you cannot feel working.
Why taking them consistently matters
A large meta-analysis pooled 44 studies of nearly two million people taking medicines for heart and circulation7. Only about 60% took at least 80% of their doses7.
The differences were meaningful. Compared with people who took less, good adherence to statins was linked to a 15% lower risk of heart disease or stroke7. It was also linked to a 45% lower risk of death from any cause7. For blood pressure medicines, the figures were 19% and 29%7. The authors estimated that around 9% of cardiovascular events in Europe could be attributed to poor adherence7.
The WHO's 2003 report on adherence makes a similar point about blood pressure. It described poor adherence as the most important cause of uncontrolled blood pressure8.
Consistency also matters for health systems and insurers. In a US study of over 857,000 chronic patients, adherence was associated with annual medical cost savings of roughly $4,400 to $5,300 per patient with comorbidities. The study followed people treated for high cholesterol, high blood pressure or diabetes9.
What consistency looks like day to day
Consistency does not mean perfection. In habit research, missing a single day did not materially affect how a new routine formed10. The aim is a steady pattern over time.
The WHO's advice for people with high blood pressure is simple. Take medicines as prescribed by your healthcare professional, keep your appointments, and do not miss or share medication4.
If a medicine is causing side effects or worry, raise it rather than quietly stopping. MedlinePlus, from the US National Library of Medicine, advises against stopping a statin on your own6. It suggests talking to your provider about any concerns6.
Ask your doctor or pharmacist what to do if you miss a dose of your own medicines. They can also help if a schedule is hard to keep.
This article is general information, not medical advice. Talk to your doctor or pharmacist about your own medicines.
Sources
- United Arab Emirates diabetes country report 2011 to 2050International Diabetes Federation, IDF Diabetes Atlas, 2024
- Age-standardised prevalence of diabetes (20 to 79 years), by countryInternational Diabetes Federation, IDF Diabetes Atlas, 2024
- The case for investment in prevention and control of non-communicable diseases in the United Arab EmiratesUAE Ministry of Health and Prevention, UNDP, WHO and UN Inter-Agency Task Force on NCDs, 2021
- Hypertension (fact sheet)World Health Organization, 2025
- Diabetes (fact sheet)World Health Organization, 2024
- StatinsMedlinePlus, US National Library of Medicine (NIH), 2025
- Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences (Chowdhury et al.)European Heart Journal, 2013
- Adherence to long-term therapies: evidence for actionWorld Health Organization, 2003
- Association among change in medical costs, level of comorbidity, and change in adherence behavior (Kymes et al.)The American Journal of Managed Care, 2016
- How are habits formed: modelling habit formation in the real world (Lally et al.), abstractEuropean Journal of Social Psychology (via ISPA repository), 2010